Catheter Precision Announces New FDA 510(k) Clearance for its VIVO System, Enabling Use in a Broader Patient Population
Catheter Precision, a wholly owned subsidiary of Flyte Aviation (VJET), received FDA 510(k) clearance for expanded labeling of its VIVO system. The clearance enables use in a broader patient population — individuals with structural heart disease undergoing catheter ablation for monomorphic ventricular tachycardia.
Key figures
- Drug Name
- VIVO (View Into Ventricular Onset)
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.